173 related articles for article (PubMed ID: 35222743)
21. Synthetic 2D Mammography Versus Standard 2D Digital Mammography: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis.
Abdullah P; Alabousi M; Ramadan S; Zawawi I; Zawawi M; Bhogadi Y; Freitas V; Patlas MN; Alabousi A
AJR Am J Roentgenol; 2021 Aug; 217(2):314-325. PubMed ID: 32966115
[No Abstract] [Full Text] [Related]
22. Clinical implications of proteolytic activity imbalance in breast cancer diagnosis.
Swellam M; Soliman HA; Abdelmaksoud MD; Nageeb AM; El Arab LR; Boshnak H
Cancer Biomark; 2014; 14(6):409-17. PubMed ID: 25335732
[TBL] [Abstract][Full Text] [Related]
23. Network Meta-analysis for the Diagnostic Approach to Pathologic Nipple Discharge.
Filipe MD; Patuleia SIS; de Jong VMT; Vriens MR; van Diest PJ; Witkamp AJ
Clin Breast Cancer; 2020 Dec; 20(6):e723-e748. PubMed ID: 32665191
[TBL] [Abstract][Full Text] [Related]
24. [Accuracy evaluation of mammography in the breast cancer screening in Asian women: a community-based follow-up study and meta analysis].
Kang M; Pang Y; Li JY; Liu LH; Liu XT
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):212-6. PubMed ID: 20450591
[TBL] [Abstract][Full Text] [Related]
25. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis.
Yang L; Wang S; Zhang L; Sheng C; Song F; Wang P; Huang Y
BMC Cancer; 2020 Jun; 20(1):499. PubMed ID: 32487106
[TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J;
Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424
[TBL] [Abstract][Full Text] [Related]
28. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
Ławicki S; Głażewska EK; Sobolewska M; Będkowska GE; Szmitkowski M
Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610
[TBL] [Abstract][Full Text] [Related]
29. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer screening using synthesized two-dimensional mammography: A systematic review and meta-analysis.
Zeng B; Yu K; Gao L; Zeng X; Zhou Q
Breast; 2021 Oct; 59():270-278. PubMed ID: 34329948
[TBL] [Abstract][Full Text] [Related]
31. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
Chu M; Fang Y; Jin Y
J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
[TBL] [Abstract][Full Text] [Related]
32. [Meta analysis of the use of Bayesian networks in breast cancer diagnosis].
Simões PW; Silva GD; Moretti GP; Simon CS; Winnikow EP; Nassar SM; Medeiros LR; Rosa MI
Cad Saude Publica; 2015 Jan; 31(1):26-38. PubMed ID: 25715289
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
34. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
[TBL] [Abstract][Full Text] [Related]
35. Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography.
Lyng MB; Kodahl AR; Binder H; Ditzel HJ
Mol Oncol; 2016 Dec; 10(10):1621-1626. PubMed ID: 27839676
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.
Thorsen SB; Christensen SL; Würtz SO; Lundberg M; Nielsen BS; Vinther L; Knowles M; Gee N; Fredriksson S; Møller S; Brünner N; Schrohl AS; Stenvang J
BMC Cancer; 2013 Dec; 13():598. PubMed ID: 24330623
[TBL] [Abstract][Full Text] [Related]
37. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic value of ultrasonography in combination with mammography for breast cancer within 2 cm: a meta-analysis].
Lin H; Lin H; Liang H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1699-703. PubMed ID: 24273283
[TBL] [Abstract][Full Text] [Related]
39. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
